UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 66 filers reported holding UROGEN PHARMA LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $239,000 | +42.3% | 17,016 | +4.7% | 0.00% | – |
| Q2 2023 | $168,000 | +14.3% | 16,252 | +2.7% | 0.00% | – |
| Q1 2023 | $147,000 | +11.4% | 15,826 | +6.3% | 0.00% | – |
| Q4 2022 | $132,000 | +6.5% | 14,887 | +0.0% | 0.00% | – |
| Q3 2022 | $124,000 | +1.6% | 14,882 | 0.0% | 0.00% | – |
| Q2 2022 | $122,000 | -12.2% | 14,882 | -7.5% | 0.00% | – |
| Q1 2022 | $139,000 | -17.3% | 16,080 | -9.3% | 0.00% | – |
| Q4 2021 | $168,000 | -46.7% | 17,726 | -5.3% | 0.00% | – |
| Q3 2021 | $315,000 | +12.1% | 18,726 | +1.6% | 0.00% | – |
| Q2 2021 | $281,000 | -86.0% | 18,428 | -82.1% | 0.00% | -100.0% |
| Q1 2021 | $2,011,000 | +15.2% | 103,215 | +6.5% | 0.00% | 0.0% |
| Q4 2020 | $1,746,000 | -11.4% | 96,904 | -5.1% | 0.00% | 0.0% |
| Q3 2020 | $1,970,000 | -26.2% | 102,119 | -0.1% | 0.00% | 0.0% |
| Q2 2020 | $2,669,000 | +48.4% | 102,197 | +1.4% | 0.00% | 0.0% |
| Q1 2020 | $1,799,000 | -47.2% | 100,813 | -1.3% | 0.00% | 0.0% |
| Q4 2019 | $3,409,000 | +630.0% | 102,143 | +420.8% | 0.00% | – |
| Q3 2019 | $467,000 | -27.6% | 19,611 | +9.3% | 0.00% | – |
| Q2 2019 | $645,000 | +45.3% | 17,939 | +48.8% | 0.00% | – |
| Q1 2019 | $444,000 | +56.9% | 12,058 | +83.7% | 0.00% | – |
| Q4 2018 | $283,000 | -20.1% | 6,563 | -12.3% | 0.00% | – |
| Q3 2018 | $354,000 | +17.6% | 7,483 | +23.6% | 0.00% | – |
| Q2 2018 | $301,000 | +19.9% | 6,056 | +19.9% | 0.00% | – |
| Q1 2018 | $251,000 | +79.3% | 5,052 | +34.5% | 0.00% | – |
| Q4 2017 | $140,000 | +154.5% | 3,755 | +114.6% | 0.00% | – |
| Q3 2017 | $55,000 | – | 1,750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,620,545 | $36,713,835 | 6.69% |
| Wildcat Capital Management, LLC | 495,606 | $6,943,440 | 2.79% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 508,883 | $7,129,451 | 2.16% |
| Opaleye Management Inc. | 320,000 | $4,483,200 | 1.46% |
| AlphaCentric Advisors LLC | 165,000 | $2,311,650 | 1.31% |
| Soleus Capital Management, L.P. | 372,000 | $5,211,720 | 0.48% |
| EAM Investors, LLC | 170,523 | $2,389,027 | 0.46% |
| RA Capital Management | 1,483,697 | $20,786,595 | 0.41% |
| Parkman Healthcare Partners LLC | 145,311 | $2,035,807 | 0.37% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,303,031 | $32,265,464 | 0.29% |